Related Experiment Video
Updated: May 21, 2026

07:26
Stimulation of Vascular Endothelial Cells Using Neutrophil Extracellular Traps in the Presence of Low-Density Lipoprotein
Published on: August 12, 2025
Neutrophil arrest by LFA-1 activation
1Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Frontiers in Immunology
|June 16, 2012
Summary
Lymphocyte function-associated antigen-1 (LFA-1) mediates neutrophil adhesion during inflammation. Inside-out signaling, involving proteins like talin-1 and Kindlin-3, regulates LFA-1
Area of Science:
- Immunology
- Cellular Biology
- Molecular Biology
Background:
- Lymphocyte function-associated antigen-1 (LFA-1) is a critical integrin for leukocyte adhesion and migration.
- LFA-1 mediates neutrophil recruitment to inflamed tissues by binding to intercellular adhesion molecules (ICAMs) on endothelial cells.
- Chemokine receptor signaling, particularly via CXCR2, triggers 'inside-out' activation of LFA-1, enhancing its ligand-binding affinity.
Purpose of the Study:
- To review the regulation of LFA-1 activation by cellular signaling and ligand binding.
- To integrate new findings on LFA-1 conformational changes into existing activation models.
- To highlight the distinct roles of talin-1 and Kindlin-3 in LFA-1 activation.
Main Methods:
- Review of existing literature on LFA-1 regulation.
- Integration of data from studies using flow chambers, intravital microscopy, and flow cytometry.
- Analysis of ligand and reporter antibody binding assays.
Main Results:
- Inside-out signaling cascades, initiated by chemokines like CXCR2, induce conformational changes in LFA-1.
- These conformational changes lead to affinity upregulation, enabling firm leukocyte adhesion.
- Talin-1 and Kindlin-3 are key co-activators that distinctly regulate LFA-1 conformational rearrangements.
Conclusions:
- LFA-1 activation is a complex process regulated by intracellular signaling pathways and protein interactions.
- Understanding LFA-1 regulation is crucial for developing therapies targeting inflammatory and immune responses.
- Talin-1 and Kindlin-3 play essential, distinct roles in modulating LFA-1 structure and function.

